Press Releases on August 6, 2019 - EIN Presswire - Press Release Distribution Service

Published on August 6, 2019 - 11:00 GMT

Neon Therapeutics Reports Second Quarter 2019 Financial Results

Planning to present more detailed data from NT-001 clinical trial evaluating NEO-PV-01 in advanced or metastatic melanoma, non-small cell lung and bladder cancers at an upcoming medical society meeting Announces U.S. Food & Drug Administration (FDA) …

Distribution channels: Business & Economy, Technology ...

Published on August 6, 2019 - 11:00 GMT

Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial Results

DOPTELET® (avatrombopag) approved by U.S. Food and Drug Administration (FDA) for treatment of chronic immune thrombocytopenia (ITP); commercial launch occurred mid-July DOPTELET approved by European Commission (EC) for treatment of severe thrombocytopenia …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2019 - 11:00 GMT

Intrepid Announces Second Quarter 2019 Results

DENVER, CO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. (Intrepid) (NYSE:IPI) today reported its results for the second quarter of 2019. Key Takeaways for Q2 2019 Net income of $5.6 million, or $0.04 per share, a $6.6 million increase compared …

Distribution channels: Business & Economy, Media, Advertising & PR ...

Published on August 6, 2019 - 11:00 GMT

Oxford Immunotec Reports Second Quarter 2019 Financial Results

Second quarter revenue of $19.6 million, an increase of 18% compared to prior year period Gross margin of 72.4%, reflecting our shift towards a pure-play kit business Positive net income of $0.6 million compared to a net loss of $6.5 million in prior year …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2019 - 11:00 GMT

R1 RCM Reports Second Quarter 2019 Results

CHICAGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months ended June 30, 2019. Second Quarter 2019 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2019 - 11:00 GMT

Peeks Social Provides Update on Status of Management Cease Trade Order

TORONTO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Peeks Social Ltd. (the "Corporation", or “Peeks”) (TSXV: PEEK, OTCQB: PKSLF) is providing this update on the status of the action taken by the Ontario Securities Commission in issuance of a Management …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on August 6, 2019 - 11:00 GMT

Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance

Record Second Quarter Product Revenues of $26.2 Million Represent a 38% Increase Over Second Quarter 2018 Full Year 2019 Revenue Guidance Raised to $112 to $116 Million Conference Call Today at 8:00am Eastern Time CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE …

Distribution channels: Business & Economy, Technology ...

Published on August 6, 2019 - 11:00 GMT

INAP Reports Second Quarter 2019 Financial Results

Second Quarter Revenue of $73.1 Million is Consistent with New 2019 Baseline as INAP Captures Sales Momentum and Records Lowest Churn Quarter in Recent Years GAAP Net Loss Attributable to INAP Shareholders of $(18.6) Million, or $(0.78) Per Share ° Cash …

Distribution channels: Business & Economy, IT Industry ...

Published on August 6, 2019 - 11:00 GMT

LGI Homes, Inc. Reports Second Quarter and YTD 2019 Results

THE WOODLANDS, Texas, Aug. 06, 2019 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (Nasdaq:LGIH) today announced results for the second quarter 2019 and the six months ended June 30, 2019. Second Quarter 2019 Results and Comparisons to Second Quarter 2018 Net Income …

Distribution channels: Business & Economy, Real Estate & Property Management ...

Published on August 6, 2019 - 11:00 GMT

EnjoyHQ Closes $2 Million in Seed Funding to Scale User Research for UX and Product Teams

SANTA MONICA, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- EnjoyHQ today announced that it has secured a $2 million seed funding round — led by Point Nine Capital and joined by investors The Venture City, LocalGlobe, Faber Ventures, Kibo Ventures Techstars …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on August 6, 2019 - 11:00 GMT

Del Frisco’s Restaurant Group, Inc. Reports Second Quarter 2019 Results

IRVING, Texas, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Del Frisco’s Restaurant Group, Inc. (“Del Frisco’s” or the “Company”) (NASDAQ: DFRG) today reported financial results for the second quarter ended June 25, 2019. On June 24, 2019, Del Frisco’s announced that …

Distribution channels: Business & Economy, Travel & Tourism Industry ...

Published on August 6, 2019 - 11:00 GMT

Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement

• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program, NL-201, is a potent IL-2/IL-15 agonist with favorable …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2019 - 11:00 GMT

Velocity Announces Positive Gold Resource Expansion Drill Results at Rozino

Highlights include: Drill hole RDD-091; 30.0m @ 0.84 g/t gold (incl. 9.0m @ 1.68 g/t gold) Drill hole RDD-103; 20.1m @ 0.99 g/t gold (incl. 5.0m @ 2.91 g/t gold) Drill hole RDD-112; 28.6m @ 1.13 (incl. 6.0m @ 3.4 g/t gold) Drill hole RDD-116; 14.1m @ 1.06 …

Distribution channels: Media, Advertising & PR

Published on August 6, 2019 - 11:00 GMT

Karyopharm Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress

− XPOVIO™ Commercial Launch Underway Following July 3rd FDA Accelerated Approval − − XPOVIO is the First and Only Prescription Medicine Approved in the U.S. for the Treatment of Patients with Multiple Myeloma whose Disease is Refractory to Proteasome …

Distribution channels: Business & Economy ...

Published on August 6, 2019 - 11:00 GMT

Lightbend Launches Nine City Roadshow Focused on Building Streaming Data Architectures on Red Hat OpenShift

SAN FRANCISCO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Lightbend today announced a nine-city roadshow focused on how to build cloud-native applications for streaming data- specific use cases, using Lightbend Platform and Red Hat® OpenShift®. Digital …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on August 6, 2019 - 11:00 GMT

Evelo Biosciences Announces Positive Interim Phase 1b Clinical Data and Provides Second Quarter 2019 Financial Results

-EDP1815 and EDP1066 were Well Tolerated with No Overall Difference Reported from Placebo- -Clinical Response Observed Consistent with Reductions in Cellular Histological and Blood Immune Cell Biomarkers in Psoriasis Patients at Low Dose of EDP1815- - …

Distribution channels: Business & Economy, Technology ...

Published on August 6, 2019 - 11:00 GMT

Martinrea International Inc. Reports Second Quarter Results and Declares Dividend

TORONTO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion …

Distribution channels: Automotive Industry, Business & Economy ...

Published on August 6, 2019 - 11:00 GMT

Emerald Health Therapeutics Outlines Production and Processing Advancements

VICTORIA, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided updates on its various cultivation and processing initiatives. “With the first 1.1 million square foot (25 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 6, 2019 - 11:00 GMT

Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center ...

The CSV-1000 Diagnostic Instrument is Considered the Standard of Care for the Measurement of Contrast Sensitivity San Diego, CA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced that …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 6, 2019 - 11:00 GMT

Todos Medical Appoints Dr. Jorge Leon as Medical Advisor

REHOVOT, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as …

Distribution channels: Media, Advertising & PR, Technology ...